Virtu Financial LLC Lucid Diagnostics Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.67 - $1.04 $13,743 - $21,333	-20,513 Reduced 59.16%	14,158 $12,000
Q1 2024 May 20, 2024	BUY	$0.81 - $1.52 $11,206 - $21,029	13,835 Added 66.4%	34,671 $28,000
Q4 2023 Feb 26, 2024	BUY	$1.16 - $1.54 $24,169 - $32,087	20,836 New	20,836 $29,000
Q1 2023 May 01, 2023	BUY	$1.17 - $1.77 $18,187 - $27,514	15,545 New	15,545 $22,000
Q1 2022 May 17, 2022	SELL	$2.85 - $5.24 $32,373 - $59,521	-11,359 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$4.87 - $11.76 $55,318 - $133,581	11,359 New	11,359 $61,000

2.54M

Ticker LUCD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 38,568,500
Market Cap $29.3M
Description
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.